Tacrolimus 0.1% ointment in nail psoriasis: A randomized controlled open-label study

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 8, 2013, Pages 1003-1006

  De Simone, C ^a   Maiorino, A ^a   Tassone, F ^a   D'Agostino, M ^a   Caldarola, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HAND; HUMAN; MALE; NAIL; NAIL PSORIASIS; NAPSI SCORE; OPEN STUDY; PARONYCHIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; NAIL DISEASES; OINTMENTS; PSORIASIS; TACROLIMUS;

EID: 84880514627     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04642.x     Document Type: Article

References (14)

1. Samman PD, Fenton DA,. The Nails in Disease, 5th edn. Butterworth-Heinemann Ltd., London, 1994.
2. Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY,. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007; 57: 1-27.
3. Augustin M, Reich K, Blome C, Schäfer I, Laass A, Radtke MA,. Nail psoriasis in Germany: epidemiology and burden of disease. Br J Dermatol 2010; 163: 580-585.
4. 41st World Medical Assembly. Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277: 925-926.
5. Rich P, Scher RK,. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003; 49: 206-212.
6. Tosti A, Ricotti C, Romanelli P, Cameli N, Piraccini BM,. Evaluation of the efficacy of acitretin therapy for nail psoriasis. Arch Dermatol 2009; 145: 269-271.
7. Lin AN,. Innovative use of topical calcineurin inhibitors. Dermatol Clin 2010; 28: 535-545.
8. Rigopoulos D, Gregoriou S, Belyayeva E, Larios G, Kontochristopoulos G, Katsambas A,. Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblended randomized study. Br J Dermatol 2009; 160: 858-860.
9. Lee DY, Kim WS, Lee KJ, et al. Tacrolimus ointment in onychodystrophy associated with eczema. J Eur Acad Dermatol Venereol 2007; 21: 1137-1138.
10. Ujiie H, Shibaki A, Akiyama M, Shimizu H,. Successful treatment of nail lichen planus with topical tacrolimus. Acta Derm Venereol 2010; 90: 218-219.
11. Kim GW, Kim SH, Seo SH, et al. Lichen striatus with nail abnormality successfully treated with tacrolimus ointment. J Dermatol 2009; 36: 616-617.
12. Kim BY, Jin SP, Won CH, Cho S,. Treatment of median canaliform nail dystrophy with topical 0.1% tacrolimus ointment. J Dermatol 2010; 37: 573-574.
13. Brown MB, Khengar RH, Turner RB, et al. Overcoming the nail barrier: a systematic investigation of ungual chemical penetration enhancement. Int J Pharm 2009; 370: 61-67.
14. Elkeeb R, AliKhan A, Elkeeb L, Hui X, Maibach HI,. Transungual drug delivery: current status. Int J Pharm 2010; 384: 1-8.